Company / R&D per Share
Cronos Group Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.01
FY2025
5-year range
$0.01 / $0.06
FY2021-FY2025
Trend
+4.9%
vs FY2024
Sector context
#204 of 208
Health Care
What the data says
Among 208 Health Care companies, Cronos Group Inc. is in the bottom 2% for r&d per share. R&D per Share returned to growth in FY2025 after 3 years of decline, reaching $0.01.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of +2.0%.
Declined from $0.02 to $0.01 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -40.2%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 208This company $0.01 Sector average $12.19
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 4.9% year-over-year.
- Ranks #204 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2021.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 5.38 (safe zone, above 2.9 threshold)
- Strong profit margin: 34.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +4.9% |
| FY2024 | $0.01 | -27.8% |
| FY2023 | $0.02 | -71.7% |
| FY2022 | $0.05 | -10.4% |
| FY2021 | $0.06 | +475.8% |
| FY2020 | $0.01 | -70.3% |
| FY2019 | $0.04 | +236.7% |
| FY2018 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026